However, over the last decade multiple novel PRL-3 inhibitors have been developed[48–53] and several natural occurring compounds are found to have PRL-3-inhibitory properties[54–58], both with clear in vitro effects on various types of cancer cells. The gene discussed is PTP4A3; the disease is cancer.